Paolo Sarmientos

Chief Executive Officer at Externautics SpA

Health Technology

Profile

Paolo Sarmientos is associated with two companies, Externautics SpA and Primm Pharma S.R.L., where he holds the position of Chief Executive Officer.

Paolo Sarmientos active positions

Companies	Position	Start
Externautics SpA Externautics SpA BiotechnologyHealth Technology Externautics SpA provides biotechnology research and development services. The firms designs and manages platforms that identify and develop novel diagnostic and therapeutic markers for oncology applications. Its technology approach is based on the screening of libraries of polyclonal antibodies and recombinant proteins, generated from the corresponding human gene library of the poorly known membrane and secreted proteins. It focuses on the identification of membrane-exposed or serum circulating proteins whose presence associate to the frequent types of human tumors. The company was founded by Guido Grandi in 2007 and is headquartered in Siena, Italy.	Chief Executive Officer	-
Primm Pharma S.R.L. Primm Pharma S.R.L. Pharmaceuticals: MajorHealth Technology Primm Pharma S.R.L. develops and produces pharmaceutical formulations for slow release injections. The company is headquartered in Milano, Italy.	Chief Executive Officer	-

All active positions of Paolo Sarmientos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paolo Sarmientos's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Externautics SpA Externautics SpA BiotechnologyHealth Technology Externautics SpA provides biotechnology research and development services. The firms designs and manages platforms that identify and develop novel diagnostic and therapeutic markers for oncology applications. Its technology approach is based on the screening of libraries of polyclonal antibodies and recombinant proteins, generated from the corresponding human gene library of the poorly known membrane and secreted proteins. It focuses on the identification of membrane-exposed or serum circulating proteins whose presence associate to the frequent types of human tumors. The company was founded by Guido Grandi in 2007 and is headquartered in Siena, Italy.	Health Technology
Primm Pharma S.R.L. Primm Pharma S.R.L. Pharmaceuticals: MajorHealth Technology Primm Pharma S.R.L. develops and produces pharmaceutical formulations for slow release injections. The company is headquartered in Milano, Italy.	Health Technology